Pfizer to Continue to Enhance the Value of its Established Products and Consumer Healthcare Businesses Within the Company, While Continuing to Strengthen its Biopharmaceutical Core NEW YORK--(BUSINESS ...

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced the next steps in the strategic alternatives review process for the company's Animal Health business. Preparations are underway to ...

Embrex, which provides inoculations for poultry against various diseases, is being sold. Pfizer Animal health, a division of health giant Pfizer, said Wednesday morning it would acquire Embrex for $17 ...

Shares of Pfizer’s animal health business, Zoetis, surged in their trading debut Friday after the company’s IPO raised $2.2 billion — the largest IPO by a U.S. company since Facebook Inc. raised $16 ...

The year was 1994. SmithKline Beecham had recently made a $30 million investment in its Lincoln animal health plant at 601 W. Cornhusker Highway. Its animal health business was doing well, with ...

TRENTON, N.J. -- Drugmaker Pfizer Inc. is aiming to boost sales of veterinary medicines in China -- and its global dominance in the animal health business -- in a joint venture with a Chinese startup ...

CHICAGO, Dec 29 (Reuters) - Pfizer Animal Health, a unit of Pfizer Inc , on Wednesday said it will buy Synbiotics Corp in a bid to expand its veterinary services into diagnostics. Synbiotics, a ...

Controversy continues to surround the use of ivermectin despite warnings from health officials and a lack of evidence that it has any preventative benefits against COVID-19. Now some proponents of the ...

Zoetis (NYSE: ZTS) is a leader in the pharmaceutical market for pets and livestock. It used to be a part of Pfizer (NYSE: PFE), but was spun off in 2012. What makes Zoetis's business attractive is the ...

NEW YORK (Reuters) - U.S. drugmakers Pfizer Inc and Wyeth said on Monday they will sell some of their animal health assets to privately held German drugmaker Boehringer Ingelheim. The divestiture is ...

(AP) - Shares of Pfizer's animal health business, Zoetis, surged in their trading debut Friday after the company's IPO raised $2.2 billion - the largest IPO by a U.S. company since Facebook Inc.